Fundraising FoxArboretum Ventures — 2019 Investments
4 investments dated 2019 · listed companies and verified rows first · show all
ViaLase develops the ViaLase Laser System, a femtosecond laser and HD imaging platform for noninvasive interventional glaucoma treatment that creates apertures through the trabecular meshwork in patients with open-angle glaucoma.
Deep TechHealthtechMedical DevicesAliso Viejo, US
Tibor Juhasz(Executive Officer, Director)inRick Lewis(Executive Officer)Scott Cooper(Executive Officer)Hadi Srass(Executive Officer)inShawn O'Neil(Executive Officer)in
BoardWilliam Link(Director)
Board seatTim Petersen· per SEC Form D
Co-investorsClarevia VenturesVersant Venture AIV Holdings
410 Medical makes LifeFlow, a hand-operated rapid infuser that lets clinicians quickly deliver blood or fluids to critically ill patients needing volume resuscitation.
HardwareHealthtechMedical DevicesDurham, US
Mark Donald Piehl(Executive Officer, Director)KYLE CHENET(Executive Officer, Director)in
BoardJEFF TERRELL(Director)inSTANLEY D. LYNALL(Director)FRED GOLDWATER(Director)inMAYANK TANEJA(Director)in
Co-investorsBallad VenturesCU Healthcare Innovation FundDuke Capital PartnersHatteras Venture PartnersOSF VenturesWellstar+2 more
Software that detects subtle vital-sign changes to warn medical professionals of post-operative patient deterioration risk.
Jen Baird, NACD.DC(Founder)inMark Salamango(Founder)in
Co-investorsInvest MichiganWMU Biosciences Research & Commercialization CenterCultivation Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.